released November 10, 2020
[Official website - 【www.mycashbackforex.com】] - Stable and profitable EA, online boutique mentor, various indicator systems, you can find customer service to obtain a professional foreign exchange expert trading indicator system after registration, and a fast and stable foreign exchange cross-platform ordering system is waiting for you !! Sign up ~->>https://www.exness-168.com/a/uiona5hf The main dealer in the foreign exchange market and represents the highest standards in the world's foreign exchange trading industry today. As the FSCM futures trading committee supervision, we always adhere to the The strict financial reporting and capital adequacy standards promoted by the association. As one of the most prestigious companies in this industry, we provide individual investors, hedge funds and corporate clients with real-time updated quote information 24 hours a day , Represents the most advanced level of trading software, fast and fair transaction implementation functions and comprehensive customer service. Our advantages are: Commission-free transactions, no commission fees Minimal spreads, the main currency is 0.4 Floating spreads from Margin trading, leverage ratio: 100: 1, 200: 1, 300: 1, 400: 1, 500: 1, 1000: 1 you can choose flexible contract size, 1K, 5K , 10K, 5 0K, 100K choose as you please Extremely low account opening standards, as low as US $ 1 Advanced global trading platform Free forex trading news Free forex trading charts Full hedge trading method, trail Stop loss function 24 hours Chinese online customer service Advanced risk management tools Click the link below to open an account now!
[Photo/IC]
BEIJING -- A new diagnostic technology developed by Chinese scientists for improving coronary heart disease treatment has received market approval from the US Food and Drug Administration (FDA), according to China's Ministry of Science and Technology Monday.
The technology, called Quantitative Flow Ratio (QFR) measurement system, was jointly developed by Pulse Medical Imaging Technology (Shanghai) Co and a group of researchers with Shanghai Jiaotong University.
Based on the computational analysis of X-ray coronary angiography, the system is able to obtain QFR noninvasively, which can evaluate coronary artery blockage and function and then help doctors decide whether a patient needs to have surgical and interventional heart procedures.
The QFR technology can assess coronary function within four minutes and increase diagnosis accuracy by 33 percent compared with conventional coronary angiography. It also has a higher accuracy rate than optical coherence tomography, a common imaging technique, said a statement released by the ministry.
The QFR was approved by China's National Medical Products Administration in July 2018.
Coronary heart disease is a condition in which the heart's blood supply is narrowed or blocked due to the build-up of plaque in the coronary artery. Since 2004, the annual growth rate of hospitalization expenses for heart diseases is much higher than the growth rate of GDP. The economic burden of Chinese patients is increasing.
The approval of QFR technology will provide a more accurate and non-invasive diagnostic device and better treatment for patients with coronary heart disease worldwide, the ministry said.
www.siliconebracelets.co.nz
www.siliconebracelets.co.nz
www.siliconebracelets.co.nz
www.siliconebracelets.co.nz
www.siliconebracelets.co.nz
liqcqpirju.bandcamp.com/album/custommadebracelets
ymvhibcqqj.bandcamp.com/album/plainblacksiliconewristbands-6
zfizvxjnkj.bandcamp.com/album/customsiliconewristbands-6
iqpcvtjkyf.bandcamp.com/album/custommadesiliconewristbands
fjxrvxzoat.bandcamp.com/album/siliconewristbandsuk
